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OBJECTIVE — To investigate the association between insulin sensitivity and glomerular
ﬁltration rate (GFR) in the community, with prespeciﬁed subgroup analyses in normoglycemic
individuals with normal GFR.
RESEARCH DESIGN AND METHODS — We investigated the cross-sectional associ-
ation between insulin sensitivity (M/I, assessed using euglycemic clamp) and cystatin C–based
GFR in a community-based cohort of elderly men (Uppsala Longitudinal Study of Adult Men
[ULSAM], n  1,070). We also investigated whether insulin sensitivity predicted the incidence
of renal dysfunction at a follow-up examination after 7 years.
RESULTS — InsulinsensitivitywasdirectlyrelatedtoGFR(multivariable-adjustedregression
coefﬁcient for 1-unit higher M/I 1.19 [95% CI 0.69–1.68]; P  0.001) after adjusting for age,
glucometabolicvariables(fastingplasmaglucose,fastingplasmainsulin,and2-hglucoseafteran
oral glucose tolerance test), cardiovascular risk factors (hypertension, dyslipidemia, and smok-
ing), and lifestyle factors (BMI, physical activity, and consumption of tea, coffee, and alcohol).
The positive multivariable-adjusted association between insulin sensitivity and GFR also re-
mained statistically signiﬁcant in participants with normal fasting plasma glucose, normal glu-
cose tolerance, and normal GFR (n  443; P  0.02). In longitudinal analyses, higher insulin
sensitivity at baseline was associated with lower risk of impaired renal function (GFR 50
ml/min per 1.73 m
2) during follow-up independently of glucometabolic variables (multivari-
able-adjusted odds ratio for 1-unit higher of M/I 0.58 [95% CI 0.40–0.84]; P  0.004).
CONCLUSIONS — Ourdatasuggestthatimpairedinsulinsensitivitymaybeinvolvedinthe
development of renal dysfunction at an early stage, before the onset of diabetes or prediabetic
glucose elevations. Further studies are needed in order to establish causality.
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educed insulin sensitivity is a key
component in the pathogenesis of
diabetes, and diabetic nephropathy
is a leading cause of end-stage renal dis-
ease (ESRD) (1). However, lower insulin
sensitivity has also been suggested to be
associatedwithimpairedrenalfunctionin
individuals without overt diabetes (2).
For instance, insulin resistance has been
shown to predict ESRD in patients with
mild renal impairment due to IgA nephri-
tis(3).Furthermore,theoppositechainof
events has also been observed; patients
with ESRD without diabetes have been
showntodevelopinsulinresistanceinthe
later stage of the disease (3,4). Based on
previous data, we hypothesized that re-
duced insulin sensitivity could be in-
volved in the development of renal
dysfunctionviapathwaysthatarenotpri-
marily mediated via increased glucose
levels.
We are aware of a few previous com-
munity-based studies that have reported
the association of reduced insulin sensi-
tivity to diminished renal function
(2,5,6). These studies, however, have
beenlimitedbytheuseofsurrogatemark-
ers of insulin sensitivity or by the use of
creatinine-basedglomerularﬁltrationrate
(GFR). Furthermore, all previous studies
have included patients with impaired
fasting glucose and impaired glucose tol-
erance,makingitdifﬁculttofullyevaluate
whether the association between insulin
sensitivity and GFR is independent of el-
evatedfastingandpostloadglucoselevels.
Moreover, most previous studies (2,5)
have included patients with impaired re-
nal function at baseline, and our knowl-
edge of the relationship between insulin
sensitivity and GFR within the normal
range in the community is limited.
Thus, we investigated the association
between insulin sensitivity, evaluated by
euglycemic clamp, and cystatin C–based
GFR in a community-based cohort of el-
derly men with prespeciﬁed subgroup
analyses in individuals with normal fast-
ing glucose, normal glucose tolerance,
andnormalGFR.Wealsoinvestigatedthe
longitudinal association between insulin
sensitivity and renal dysfunction during
follow-up and evaluated whether this as-
sociationwasindependentofothergluco-
metabolic factors.
RESEARCH DESIGN AND
METHODS
Study sample
The design and selection criteria of the
UppsalaLongitudinalStudyofAdultMen
(ULSAM) have been previously described
(7), and further details can be found on
the Internet (http://www.pubcare.uu.se/
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(1991–1995), 1,221 men (mean age 71
years) were investigated. We excluded
151 men for the following reasons: un-
availableclampdata(n61),unavailable
cystatin C data (n  26), hospitalization
forkidneyfailurebeforethebaseline(n
4),anduseofdiabetesmedicine(n60).
Thus, the present study sample was com-
prised of 1,070 individuals. We also per-
formed analyses in participants with
normal fasting glucose and glucose toler-
ance (n  517) and in participants with
normal fasting glucose, normal glucose
tolerance, and normal GFR (50 ml/min
per 1.73 m
2, n  433). Follow-up data at
the fourth examination cycle (1998–
2002; mean age 77) was available in 694
participants. All participants gave written
informedconsent,andtheethicscommit-
tee of Uppsala University approved the
study protocol.
Clinical and biochemical evaluation
at baseline
Serum cystatin C was measured by latex
enhanced reagent (N Latex Cystatin C;
Siemens) using a BN ProSpec analyzer
(Siemens). GFR was calculated from se-
rum cystatin C levels, which have been
shown to be closely correlated with io-
hexol clearance (8) in milligrams per liter
by the formula y  77.24x
1.2623.
The euglycemic-hyperinsulinemic
clamp technique according to DeFronzo
(9)wasused,withaslightmodiﬁcationto
suppress hepatic glucose production
(10), for estimation of in vivo sensitivity
to insulin. Insulin (Actrapid Human;
Novo, Copenhagen, Denmark) was in-
fused in a primary dose for the ﬁrst 10
minandthenasacontinuousinfusion(56
mU/min per body surface area in meters
squared), during which DeFronzo (9)
used 40 mU/min per body surface area in
meters squared, for2ht omaintain
steady-state hyperinsulinemia. The target
plasma glucose level was 5.1 mmol/l,
maintained by measuring plasma glucose
every 5 min. The glucose infusion rate
during the last hour was used as a mea-
sure of insulin sensitivity (M value). The
insulin sensitivity index (M/I ratio) was
calculated by dividing M by the mean in-
sulin concentration during the same pe-
riod of the clamp. M/I thus represents the
amount of glucose metabolized per unit
of plasma insulin.
Anoralglucosetolerancetest(OGTT)
was performed; subjects ingested 75 g
glucose dissolved in 300 ml of water, and
blood samples for plasma glucose and in-
sulin were drawn immediately before and
30, 60, 90, and 120 min after ingestion of
glucose. Plasma glucose was measured by
the glucose dehydrogenase method
(Gluc-DH; Merck, Darmstadt, Germany).
Plasma insulin was assayed using an en-
zymatic-immunological assay (Enzym-
mun; Boehringer Mannheim, Germany)
performed in an ES300 automatic ana-
lyzer (Boehringer Mannheim).
Urinary albumin excretion rate was
calculated using the amount of albumin
in urine collected during the night. The
subjects were instructed to void immedi-
atelybeforegoingtobedandtorecordthe
time.Allsamplesduringthenightandthe
ﬁrst sample of urine after rising were col-
lected and used for the analysis (Albumin
RIA 100; Pharmacia, Uppsala, Sweden).
Coffee, tea, and alcohol consumption
were recorded using a 7-day precoded
food diary, based on instructions of a di-
etitian. Daily intakes were calculated us-
ing a computer program and the Swedish
National Food Administration Database
(SLV Database, 1990). Participants re-
ported leisure-time physical activity on a
standardized questionnaire (7). Smoking
statuswasbasedoninterviewsperformed
by a nurse.
Diabetes was diagnosed as fasting
plasma glucose 7.0 mmol/l (126
mg/dl) or 2-h postload glucose level
11.1 mmol/l (200 mg/dl) or by the
use of oral hypoglycaemic agents or in-
sulin. Impaired glucose tolerance was
deﬁned as a 2-h postload glucose value
of 7.8–11 mmol/l (140–199 mg/dl).
Impaired fasting glucose was deﬁned as
fasting plasma glucose of 5.6–6.9
mmol/l (100–125 mg/dl). BMI was cal-
culated as weight in kilograms divided by
the square of height in meters. Hyperten-
sion was deﬁned as use of antihypertensive
medication or having a systolic blood pres-
sure 140 mmHg or diastolic blood pres-
sure 90 mmHg. Dyslipidemia was
deﬁned as total cholesterol 5 mmol/l
(200 mg/dl) or HDL cholesterol 1.0
mmol/l (40 mg/dl) or the use of lipid-
lowering medication.
Follow-up and outcome
Renal impairment during follow-up was
deﬁned as having a GFR 50 ml/min per
1.73 m
2 at the fourth examination cycle
(after 7 years) or as being hospitalized
for renal failure during follow-up. We de-
ﬁned renal dysfunction as GFR 50 ml/
minper1.73m
2,accordingtothecurrent
deﬁnitionusedinclinicalpracticeinSwe-
den for individuals older than 50 years.
Subjects who were hospitalized for renal
failure were identiﬁed by the Swedish
hospital discharge register using the fol-
lowingICDcodes:renalfailure;584–588
(ICD-9) and N17–N19 (ICD-10).
Statistical analysis
If necessary, logarithmic transformation
was performed to achieve normal distri-
bution (fasting plasma glucose, 2-h
plasma glucose, fasting plasma insulin,
and 2-h plasma insulin). Linear regres-
sion analyses were used to assess the
cross-sectional associations between in-
sulin sensitivity index (M/I; independent
variable) and cystatin C–based GFR (de-
pendent variable). The following models
were used:
● Model A: age adjusted
● Model B (glucometabolic model): ad-
justed for age, fasting plasma glucose,
fasting plasma insulin, and 2-h glucose
● Model C (cardiovascular risk factor
model): adjusted for age, hypertension,
dyslipidemia, and smoking
● Model D (lifestyle model): adjusted for
age, BMI, physical activity, and con-
sumption of tea, coffee, and alcohol
● Model E (combined model): adjusted
for covariates in models A–D
We also performed the above analy-
ses in the following prespeciﬁed sub-
groups: 1) normal fasting glucose and
normal glucose tolerance (n  517) and
2) normal fasting glucose, normal glucose
tolerance, and normal GFR (50 ml/min
per1.73m
2,n433).Insecondaryanal-
yses, the separate addition of urinary al-
bumin excretion rate (modeled as
normoalbuminuria [20 g/min], mi-
croalbuminuria [20–200 g/min], or
macroalbuminuria [200 g/min]), se-
rum triglycerides, and 2-h plasma insulin
at the OGTT to multivariable model E
were also investigated. We exchanged the
hypertension variable in model C for sys-
tolic and diastolic blood pressure and use
of -blockers, -blockers, ACE inhibi-
tors, diuretics, and calcium antagonist;
we also exchanged the dyslipidemia vari-
ableinmodelCfortotalcholesterol,HDL
cholesterol, and use of lipid-lowering
medication. Moreover, we investigated
the association of insulin sensitivity to
creatinine-based GFR (calculated with
the Modiﬁcation of Diet in Renal Disease
[MDRD]) formula (11). Also, we investi-
gated the association between the glucose
disposal rate (M) and GFR and the asso-
ciation between 2-h plasma insulin (as a
Nerpin and Associates
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and GFR. The potential nonlinearity of
the association between M/I and GFR was
investigated using penalized regression
splines.
Logistic regression was used to relate
insulin sensitivity to renal dysfunction
during follow-up. In these analyses, 108
participants with impaired GFR at base-
line (50 ml/min per 1.73 m
2) were ex-
cluded, which leaves 586 participants
with longitudinal data. Given the moder-
ate sample size and the low number of
participants that developed renal dys-
function during follow-up (n  32), we
limited the multivariable modeling to
modelsAandB,describedabove.Wealso
performed these longitudinal analyses in
participants with normal fasting glucose
and normal glucose tolerance. In second-
ary analyses, we added baseline GFR to
the longitudinal multivariable logistic re-
gression models. A two-sided P value
0.05 was regarded as signiﬁcant in all
analyses. The statistical software package
STATA 10.0 (Stata Corp, College Station,
TX) was used for all analyses.
RESULTS
Baseline characteristics
Baseline characteristics of the study pop-
ulation and the different subsamples are
presented in Table 1.
Cross-sectional association between
insulin sensitivity and GFR
In the whole cohort, 1 unit higher of M/I
was signiﬁcantly associated with 0.85–
1.19 ml/min per 1.73 m
2 higher GFR ad-
justing for age (model A), glucometabolic
variables (model B), cardiovascular risk
factors (model C), lifestyle factors (model
D), and the combination of all covariates
inmodelsA–D(modelE,Table2).Inpar-
ticipants with normal fasting glucose and
normal glucose tolerance, the positive as-
sociation between insulin sensitivity and
GFR remained essentially the same in all
models (models A–E; Table 2). After fur-
ther exclusion of participants with im-
paired GFR (50 ml/min per 1.73 m
2)
theassociationbetweeninsulinsensitivity
and GFR remained statistically signiﬁcant
in all models but with lower regression
coefﬁcients (Table 2).
Insecondaryanalyses,theassociation
between insulin sensitivity and GFR was
not substantially altered after further ad-
justment for urinary albumin excretion
rate, serum triglycerides, or 2-h plasma
insulin at an OGTT; when exchanging
the hypertension variable in model C
for systolic and diastolic blood pressure
and use of -blockers, -blockers,
ACE-inhibitors, diuretics, and calcium
antagonist; or when exchanging the
dyslipidemia variable in model C for to-
tal cholesterol, HDL cholesterol, and
use of lipid-lowering medication (data
not shown). The association of insulin
sensitivity with creatinine-based GFR
wasessentiallysimilartotheassociation
of insulin sensitivity with cystatin
C–based GFR (model E,  coefﬁcient
1.05 [95% CI 0.61–1.50]; P  0.001).
The association between M and GFR
was similar to the association between
M/I and GFR (model E, 1.09 [0.44–
1.75]; P  0.001). No deviation from
linearity was detected in the association
Table 1—Baseline characteristics of the whole study population and different subsamples
Variable Total cohort
Normal fasting glucose
and normal glucose tolerance
Normal fasting glucose,
normal glucose tolerance,
and GFR 50 ml/min per 1.73m
2
n 1,070 517 433
Age (years) 71.0 	 0.59 71.0 	 0.58 71.0 	 0.56
Glomerular ﬁltration rate (ml/min per 1.73m
2) 61.5 	 13.7 61.5 	 13.0 65.3 	 10.4
Urinary albumin excretion rate (g/min) 21.9 	 84.0 19.0 	 86.6 11.9 	 33.0
Fasting plasma glucose (mmol/l) 5.5 	 0.9 5.1 	 0.3 5.1 	 0.3
Insulin sensitivity (M/I) (100 
 mg   kg
1  
body weight
1   min
1   mU
1   l
1)
5.2 	 2.5 6.2 	 2.4 6.3 	 2.4
OGTT 2-h glucose (mmol/l) 7.7 	 3.0 5.8 	 1.2 5.7 	 1.2
Fasting plasma insulin (mu/l) 12.5 	 7.2 10.6 	 5.3 10.3 	 4.9
Systolic blood pressure (mmHg) 146.7 	 18.5 143.9 	 18.3 143.3 	 17.3
Diastolic blood pressure (mmHg) 83.9 	 9.4 82.7 	 9.3 82.5 	 8.9
BMI (kg/m
2) 26.2 	 3.4 25.2 	 3.0 25.1 	 2.9
Coffee (cups per day) 3.4 	 1.6 3.4 	 1.7 3.5 	 1.6
Tea (cups per day) 0.67 	 1.0 0.73 	 1.2 0.73 	 1.2
Alcohol (g/day) 6.4 	 7.0 6.4 	 7.0 6.6 	 7.1
Diabetes 61 (5.7) — —
Impaired fasting glucose 365 (34.0) — —
Impaired glucose tolerance 410 (38.3) — —
Smoking 221 (20.7) 125 (24.2) 100 (23.1)
Dyslipidemia 938 (87.7) 446 (86.3) 372 (85.9)
Hypertension 789 (73.7) 351 (67.9) 289 (66.7)
Physical activity level
Sedentary 36 (3.7) 15 (3.2) 12 (3.0)
Moderate 324 (33.4) 151 (31.8) 124 (31.2)
Regular 551 (56.8) 276 (58.2) 229 (57.8)
Athletic 60 (6.2) 32 (6.8) 31 (7.8)
Date are means 	 SD for continuous variables and n (%) for dichotomous variables.
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sion splines. Moreover, 2-h plasma in-
sulin was inversely associated with GFR
in all multivariable models (A–E; P 
0.001 for all) and after adding M/I to
multivariable model E (2.07 [3.95
to 0.19]); P  0.03).
Insulin sensitivity and the
development of renal dysfunction
Of the participants with normal GFR
(50ml/minper1.73m
2)atbaseline,32
developed renal dysfunction during fol-
low-up. Of these, none underwent dialy-
sis or renal transplantation, suggesting
that the renal impairment during fol-
low-upwasnotsevere.Moreover,onlysix
of these participants were diagnosed with
diabetes, indicating that diabetic ne-
phropathy was not the main underlying
cause for the renal dysfunction.
Higher insulin sensitivity was bor-
derline signiﬁcantly associated with
lower risk of developing renal dysfunc-
tion in the age-adjusted models (model
A) and after adjustment for glucometa-
bolic variables (model B). Interestingly,
the association between insulin sensi-
tivity and renal dysfunction appeared
stronger in the subsample with normal
fasting glucose and normal glucose tol-
erance (Table 3). Further addition of
baseline GFR to multivariable model B
attenuated this association in the whole
sample (odds ratio [OR] 0.86, [95% CI
0.68–1.08]; P  0.19). Still, the associ-
ation between insulin sensitivity and
impaired renal function remained sta-
tistically signiﬁcant in the participants
with normal glucose after the addition
of baseline GFR to multivariable model
B (0.61 [0.42–0.91]; P  0.01).
CONCLUSIONS— We identiﬁed a
signiﬁcant positive association between
insulinsensitivityandGFRinacommu-
nity-based sample of elderly men. This
association was also consistent in par-
ticipants with normal fasting glucose,
normal glucose tolerance, and normal
renal function and after taking gluco-
metabolic variables, cardiovascular risk
factors, and lifestyle factors into ac-
count in multivariable analyses. More-
over, in longitudinal analyses, insulin
sensitivity at baseline predicted subse-
quent renal dysfunction independently
of other glucometabolic variables. Our
data suggest that the association be-
tween impaired insulin sensitivity and
lower GFR is not primarily mediated via
elevated glucose levels and that this as-
sociation is evident already in individu-
als without any clinical signs of kidney
dysfunction or glucose dysregulation.
Comparison with the literature
Our ﬁndings are in accordance with pre-
vious community-based studies that have
investigated the cross-sectional associa-
tionofinsulinsensitivityandGFR(2,5,6).
In these studies, decreased insulin sensi-
tivity (assessed by serum insulin levels or
homeostasis model assessment [HOMA]
insulin sensitivity) was associated with
impaired renal function. However, both
fasting insulin and HOMA insulin sensi-
tivity are limited as indicators of insulin
sensitivity because they are also highly
inﬂuencedbytheindividual’s-cellfunc-
tion, i.e., insulin secretion. The asso-
ciation between insulin sensitivity, as
evaluated by the gold standard euglyce-
mic clamp technique, and GFR has not
been previously reported. Furthermore,
nopreviousstudieshaveanalyzedthisas-
sociation in individuals with normal glu-
cose levels and normal GFR.
We are aware of one previous study
that has evaluated the longitudinal asso-
ciationbetweeninsulinsensitivityandin-
cidence of renal dysfunction. In contrast
to the present study, Fox et al. (12) re-
ported that HOMA insulin resistance did
notsigniﬁcantlypredictrenaldysfunction
Table 2—The association of insulin sensitivity index (M/I) and GFR: multivariable linear regression
Model Total cohort (n  1,070)
Normal fasting glucose and normal
glucose tolerance (n  517)
Normal fasting glucose, normal
glucose tolerance, and GFR50
ml/min per 1.73m
2 (n  433)
 coefﬁcient (95% CI) P  coefﬁcient (95% CI) P  coefﬁcient (95% CI) P
A 0.86 (0.53–1.19) 0.001 1.03 (0.57–1.50) 0.001 0.52 (0.11–0.93) 0.01
B 1.10 (0.67–1.53) 0.001 0.79 (0.25–1.33) 0.004 0.54 (0.07–1.00) 0.02
C 0.85 (0.52–1.19) 0.001 1.03 (0.56–1.56) 0.001 0.55 (0.14–0.97) 0.01
D 0.88 (0.45–1.31) 0.001 1.09 (0.51–1.67) 0.001 0.61 (0.11–1.10) 0.02
E 1.19 (0.69–1.68) 0.001 0.86 (0.23–1.49) 0.007 0.66 (0.12–1.19) 0.02
Data are regression coefﬁcients for a 1-unit higher M/I. Model A is adjusted for age, model B is adjusted for age and glucometabolic factors (fasting plasma glucose,
fasting plasma insulin, and 2-h plasma glucose at OGTT), model C is adjusted for age and cardiovascular risk factors (hypertension, dyslipidemia, and smoking),
model D is adjusted for age and lifestyle factors (BMI, physical activity, and consumption of tea, coffee and alcohol), and model E is adjusted for all covariates in
models A–D.
Table 3—The association of insulin sensitivity index (M/I) and the incidence of renal dysfunction in participants with GFR >50 ml/min per
1.73 m
2 at baseline: multivariable logistic regression
Model Total cohort*
Normal fasting glucose and
normal glucose tolerance†
OR (95% CI) P OR (95% CI) P
A 0.85 (0.72–1.00) 0.055 0.67 (0.51–0.89) 0.006
B 0.82 (0.65–1.02) 0.071 0.58 (0.40–0.84) 0.004
Data are ORs for a 1-unit higher M/I. Model A is adjusted for age, and model B is adjusted for age, fasting plasma glucose, fasting plasma insulin, and 2-h glucose
at an OGTT. *Number of events per number at risk: 32 of 586. †Number of events per number at risk: 16 of 295.
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els. The discrepant results could perhaps
be explained by differences between the
studies in the assessment of insulin sensi-
tivity or that our study sample consisted
exclusively of elderly men. However, no
ﬁrm conclusions should be drawn from
the present study with regard to the lon-
gitudinalassociationbetweeninsulinsen-
sitivity and incident renal impairment
due to the moderate number of events
during follow-up, particularly in the sub-
sample with normal glucose levels. Fur-
ther studies are needed in order to shed
further light on this issue.
Possible mechanisms for observed
associations
Impaired insulin sensitivity and compen-
satory hyperinsulinemia have been sug-
gested to contribute to development of
renal injury via a number of different
pathophysiologic pathways: insulin per
se stimulates the expression and activa-
tion of IGF-1, transforming growth fac-
tor-, endothelin-1, and components of
the renin-angiotensin-aldosterone system
(13). These factors have been shown to
promote mitogenic and ﬁbrotic processes
in the kidney, such as proliferation of
mesangial cells and extracellular matrix
expansion (13). Moreover, insulin resis-
tance and hyperinsulinemia are closely
associated with oxidative stress (14),
which could promote renal injury via de-
creased production and availability of ni-
tric oxide (15) and accelerated formation
of glycoxidation and lipid peroxidation
products (16–18). Also, insulin resis-
tance is linked to increased activity of
proinﬂammatory cytokines and adipo-
kines, factors that have been suggested to
contribute to the progression of renal dis-
ease (19). There are also data suggesting
that renal insufﬁciency suppresses renal
clearance of insulin, leading to higher cir-
culating levels of insulin and thus further
stimulation of the deleterious effect of in-
sulin on the kidney, i.e., leading to a vi-
cious circle (20). We are not able to fully
evaluate the potential inﬂuence of re-
duced renal clearance of insulin in our
study, but the strong positive association
betweentheglucosedisposalrate(M)and
GFR and the similar results in individuals
with normal renal function indicate that
the potential impact of a reduced renal
clearance of insulin on the present results
is not likely to be major.
The fact that the association between
insulin sensitivity and GFR remained ro-
bust after adjustment for both fasting and
2-h postload insulin would argue against
hyperinsulinemia as the sole explanation of
our ﬁndings. Also, as 2-h postload insulin
was associated with GFR independently of
insulin sensitivity and all potential con-
founders in model E, it is possible that
daylong hyperinsulinemia per se inde-
pendently contributes to a reduced GFR.
Since these two conditions are so closely
interrelated, it is not possible to fully dis-
entangle the individual contributions of
hyperinsulinemia and insulin resistance
to GFR in the present study.
There are also some other potential
mechanisms that merit discussion: re-
duced insulin sensitivity may lead to dia-
betes, which is one of the leading causes
of renal failure. However, as insulin sen-
sitivity was associated with GFR in indi-
viduals with otherwise normal glucose
metabolismafteradjustmentforbothfast-
ing and postload glucose levels, higher
glucose levels are not a likely explanation
for the results in the present study. Also,
insulin sensitivity is associated with sev-
eral glucometabolic, cardiovascular risk,
and lifestyle factors that have been shown
to be associated with a reduced GFR and
the development of chronic kidney dis-
ease (2,12,21–23). The fact that insulin
sensitivity remained signiﬁcantly associ-
ated with GFR in all multivariable models
suggests that confounding by these fac-
tors does not explain our ﬁndings.
Clinical implementations
While the cross-sectional regression coef-
ﬁcients suggest that the magnitude of the
association between insulin sensitivity
and GFR could be modest, the ORs from
the longitudinal logistic regression analy-
ses imply that the potential impact of
lower insulin sensitivity on the develop-
mentofrenaldysfunctionovertimecould
be substantial. Since no ﬁrm conclusions
regarding causality and effect size should
be drawn from observational data, inter-
vention trials are needed to properly in-
vestigate these issues.
Strengths and limitations
Thestrengthsofourinvestigationinclude
the large, homogenous, community-
based study sample with detailed charac-
terization of glucometabolic variables,
cardiovascular risk factors, and lifestyle
factors. Moreover, the ULSAM cohort is
the largest cohort in the world examined
with the euglycemic clamp technique.
Furthermore, serum levels of cystatin C
wereusedtoestimateGFR;thismethodis
considered to be a more reliable indicator
of kidney function than estimation via
creatinine-based GFR, particularly in the
elderly (24).
Limitations include the unknown
generalizability to women and other age-
and ethnic groups. Also, multiple statisti-
calanalysesinseveraldifferentsubgroups
were performed. Yet, because of multiple
testing, the consistency of results across
all models and subsamples makes it un-
likely that the observed associations
arose by chance. Moreover, we have not
used the gold standard method to mea-
sure GFR (isotope clearance measure-
ments). However, isotope clearance
measurement is seldom used in epide-
miological research, as it is a very time
consuming and costly procedure. Im-
portantly, cystatin C–based GFRs have
been shown to be closely correlated
with GFR assessed by isotope clearance
measurements (8).
In summary, in a community-based
sample of elderly men, lower insulin sen-
sitivity was associated with lower renal
function, even in individuals with normal
glucose levels and normal GFR. Our data
suggest that impaired insulin sensitivity
may be involved in the development of re-
nal dysfunction at an early stage, before the
onset of diabetes or pre-diabetes glucose
elevations. Further studies are needed
toestablishcausalityandtoevaluatethe
clinical implications of our ﬁndings.
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